Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlycoMimetics Inc (NASDAQ:GLYC)

3.91
Delayed Data
As of Feb 12
 +0.10 / +2.62%
Today’s Change
3.70
Today|||52-Week Range
9.22
-31.64%
Year-to-Date
No recent news for GlycoMimetics Inc.

Today’s Trading

Previous close3.81
Today’s open3.85
Day’s range3.78 - 4.08
Volume1,298
Average volume (3 months)17,153
Market cap$74.4M
Dividend yield--
Data as of 3:54pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)-5.26%
Earnings growth (this year)+10.00%
Earnings growth (next 5 years)--
Revenue growth (last year)+276.37%
P/E ratioNM
Price/Sales8.84
Price/Book1.46

Competitors

 Today’s
change
Today’s
% change
ATNMActinium Pharmaceuti...+0.06+3.45%
NVLSNivalis Therapeutics...+0.24+5.36%
TNXPTonix Pharmaceutical...+0.24+6.32%
CPIXCumberland Pharmaceu...-0.16-3.34%
Data as of 4:02pm ET, 02/12/2016

Financials

Next reporting dateMarch 15, 2016
EPS forecast (this quarter)-$0.42
Annual revenue (last year)$15.0M
Annual profit (last year)-$11.1M
Net profit margin-74.01%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Rachel K. King
Chief Financial Officer &
Head-Media Relations
Brian M. Hahn
Corporate headquarters
Gaithersburg, Maryland

Forecasts

Partner Offers